Prescription Drugs: Pricing for Taxpayer-Funded Research
The House Committee on Energy and Commerce is reviewing this bill. It has not moved since August 13, 2026. The committee must decide whether to hold a vote before the bill can advance further.
The bill is supported only by Democrats and faces strong opposition from the pharmaceutical industry. It is unlikely to move forward without support from the other party.
Govbase has not yet run an impact analysis on this legislation.
Referred to the House Committee on Energy and Commerce.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
No votes, news coverage, or related bills recorded for this bill yet.
Document Type
Congressional Bill
Official Title
Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2026
Analysis generated by AI. Always verify with official sources.